These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 3872156)

  • 21. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
    Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of age at onset on the duration of treatment in idiopathic adult polymyositis and dermatomyositis.
    McKendry RJ
    Arch Intern Med; 1987 Nov; 147(11):1989-91. PubMed ID: 3675101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
    Marie I; Hachulla E; Hatron PY; Hellot MF; Levesque H; Devulder B; Courtois H
    J Rheumatol; 2001 Oct; 28(10):2230-7. PubMed ID: 11669162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nerve conduction studies in patients with dermatomyositis or polymyositis.
    Wang Y; Cui LY; Chen L; Liu MS; Qi X; Li BH; DU H
    Chin Med J (Engl); 2010 Mar; 123(5):523-6. PubMed ID: 20367974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of early treatment in polymyositis and dermatomyositis.
    Naji P; Shahram F; Nadji A; Davatchi F
    Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between clinical features and distribution of mononuclear cells in muscle of patients with polymyositis.
    Kalovidouris AE; Stoesz E; Muller J; Kimes T; Brandt KD
    J Rheumatol; 1988 Sep; 15(9):1401-6. PubMed ID: 3199400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis.
    Louthrenoo W; Weerayutwattana N; Lertprasertsuke N; Sukitawut W
    J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective study of polymyositis in Auckland over 10 years.
    Ogle S
    N Z Med J; 1980 Dec; 92(673):433-5. PubMed ID: 6937784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE; Helmers SB
    Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
    Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
    Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
    Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
    Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune manifestations of inflammatory muscle disease.
    Targoff IN
    Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases.
    Tymms KE; Webb J
    J Rheumatol; 1985 Dec; 12(6):1140-8. PubMed ID: 4093921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.